BCK Capital Management’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

BCK Capital Management’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-15,000	Closed	-$901K	–	166
2021 Q1	$901K	Buy	+15,000	New	+$543K	0.5%	51

BCK Capital Management's PAND Position: Q2 2021 in Review

BCK Capital Management sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 15,000 shares — an estimated $901K sold.

BCK Capital Management first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $901K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

BCK Capital Management reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
BCK Capital Management sold 15,000 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $901K.
BCK Capital Management first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
BCK Capital Management's Pandion Therapeutics Inc. Common Stock position peaked at $901K in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on BCK Capital Management's 13F filing for Q2 2021, filed 20 Jul 2021.